Your browser doesn't support javascript.
loading
HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.
Lin, Zhansong; Bashirova, Arman A; Viard, Mathias; Garner, Lee; Quastel, Max; Beiersdorfer, Maya; Kasprzak, Wojciech K; Akdag, Marjan; Yuki, Yuko; Ojeda, Pedro; Das, Sudipto; Andresson, Thorkell; Naranbhai, Vivek; Horowitz, Amir; McMichael, Andrew J; Hoelzemer, Angelique; Gillespie, Geraldine M; Garcia-Beltran, Wilfredo F; Carrington, Mary.
Afiliação
  • Lin Z; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Bashirova AA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Viard M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Garner L; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Quastel M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Beiersdorfer M; Centre for Immuno-Oncology, University of Oxford, Oxford, UK.
  • Kasprzak WK; Centre for Immuno-Oncology, University of Oxford, Oxford, UK.
  • Akdag M; Leibniz Institute of Virology, Hamburg, Germany.
  • Yuki Y; 1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ojeda P; German Center for Infection Research (DZIF), Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Das S; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Andresson T; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Naranbhai V; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Horowitz A; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • McMichael AJ; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hoelzemer A; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Gillespie GM; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Garcia-Beltran WF; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Carrington M; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Nat Immunol ; 24(7): 1087-1097, 2023 07.
Article em En | MEDLINE | ID: mdl-37264229
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinais Direcionadores de Proteínas / Células Matadoras Naturais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinais Direcionadores de Proteínas / Células Matadoras Naturais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos